Next Quarterly Earnings
Monday, September 21, 2026
CW 39
Pre-Market
In 25 days
Confirmed by the company
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Abivax
Abivax is a French biopharmaceutical company specializing in the development of innovative therapeutics for the treatment of chronic inflammatory diseases. Through its clinical research, Abivax specifically addresses significant unmet medical needs in the treatment of ulcerative colitis.
Frequently asked questions
When will Abivax report its next quarterly earnings?
Abivax is scheduled to report its next quarterly earnings on 09/21/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Abivax last report quarterly earnings?
Abivax last reported quarterly earnings on 5/22/2026 (Q1 2026). Earnings per share (EPS) came in at -0.61 EUR.
How often has Abivax beaten expectations?
Abivax has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
How do I add the Abivax earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
+12.5%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Abivax
Country
🇫🇷
More Financial Information